MYRIAD GENETICS, INC. (MYGN) Operating margin 2016–2025
MYRIAD GENETICS, INC. (MYGN) operating margin by fiscal year — reported operating income divided by reported revenue.
-47.0%FY2025 · since FY2016: 6.0% → -47.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -47.0% | -32.2 pp |
| FY2024 | -14.7% | +19.4 pp |
| FY2023 | -34.2% | -13.4 pp |
| FY2022 | -20.7% | +6.9 pp |
| FY2021 | -27.6% | +24.4 pp |
| FY2020 | -52.0% | -15.7 pp |
| FY2019 | -36.3% | -37.2 pp |
| FY2018 | 0.9% | -15.5 pp |
| FY2017 | 16.4% | +10.4 pp |
| FY2016 | 6.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MYGN financial trends
MYGN RevenueMYGN Net incomeMYGN Net marginMYGN Gross profitMYGN Gross marginMYGN Operating incomeMYGN Operating cash flowMYGN Free cash flowMYGN Capital expendituresMYGN Return on equityMYGN Stock buybacksMYGN Dividends paidMYGN Total assetsMYGN Total liabilitiesMYGN Shareholders’ equityMYGN overview →